Huron Consulting Group, Inc.

  • Market Cap: Small Cap
  • Industry: Miscellaneous
  • ISIN: US4474621020
USD
170.52
5.71 (3.46%)
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-summaryCompany CV
About Huron Consulting Group, Inc. stock-summary
stock-summary
Huron Consulting Group, Inc.
Miscellaneous
Huron Consulting Group Inc. is a global professional services firm. The Company offers solutions in operations, advisory services, technology and analytics for healthcare, higher education, life sciences and commercial sectors. The Company's segments include Healthcare, Education and Life Sciences, and Business Advisory. Its Healthcare segment provides advisory services, from strategy setting through implementation, in the areas of organizational and resource alignment, clinical transformation, financial and operational performance, patient and caregiver engagement, and technology implementation and optimization. Its Education and Life Sciences segment provides management consulting and technology solutions to the higher education and academic medical centers, pharmaceutical and medical device, biotechnology and research industries. The Business Advisory segment's primary service lines include Enterprise Solutions and Analytics, and Business Advisory.
Company Coordinates stock-summary
Company Details
550 W van Buren St , CHICAGO IL : 60607-3827
Registrar Details
stock-recommendation Shareholding
Shareholding Snapshotstock-summary
Shareholding Compare (%holding) stock-summary
Majority shareholders

Domestic Funds

Domestic Funds

Held in 77 Schemes (42.03%)

Foreign Institutions

Held by 119 Foreign Institutions (18.2%)

Strategic Entities with highest holding

Highest Public shareholder

stock-summary Board of Directorsstock-summary
Management
Designation
Mr. John McCartney
Non-Executive Independent Chairman of the Board
Mr. James Roth
Chief Executive Officer, Director
Mr. Hugh Sawyer
Director
Mr. H. Eugene Lockhart
Independent Director
Ms. Ekta Singh-Bushell
Independent Director
Ms. Debra Zumwalt
Independent Director
stock-recommendation Stock DNA
Revenue and Profits:
Net Sales:
412 Million
(Quarterly Results - Jun 2025)
Net Profit:
19 Million
stock-summary
Industry

Miscellaneous

stock-summary
Market cap

USD 2,753 Million (Small Cap)

stock-summary
P/E

23.00

stock-summary
Industry P/E

NA

stock-summary
Dividend Yield

0.00%

stock-summary
Debt Equity

1.28

stock-summary
Return on Equity

26.10%

stock-summary
Price to Book

5.80